Cameron Durrant is the founder of Humanigen. Humanigen has raised $72M in total funding. Latest round: Series C. Based in Burlingame, California.
Cameron Durrant is the CEO of Humanigen, a clinical stage biopharmaceutical company. Humanigen focuses on preventing and treating cytokine storm using lenzilumab, its proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody. The company recently completed an equity financing round, raising approximately $72 million from a group of healthcare investors.
Full founder directory · Investor directory · Company funding database · Fundraising library